These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 25734208)

  • 1. Postmenopausal hormone therapy and blood pressure revisited.
    Pines A
    Climacteric; 2015 Feb; 18(1):104-5. PubMed ID: 25734208
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultrastructure study of postmenopausal endometria of tibolone, conjugated estrogen + medroxyprogesterone acetate and tamoxifen users.
    Nas T; Sargon MF; Celik HH; Keskin PO; Gürsoy RH; Biberoglu K
    Saudi Med J; 2007 Dec; 28(12):1917-9. PubMed ID: 18060233
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of estrogen-only treatment in postmenopausal women.
    Campagnoli C; Abbà C; Ambroggio S; Peris C
    JAMA; 2004 Aug; 292(6):684; author reply 685-6. PubMed ID: 15304458
    [No Abstract]   [Full Text] [Related]  

  • 4. Sympathetic skin response in women receiving hormone replacement therapy.
    Kutlar I; Yilmaz M; Balat O
    Int J Gynaecol Obstet; 2004 Feb; 84(2):181-2. PubMed ID: 14871527
    [No Abstract]   [Full Text] [Related]  

  • 5. Postmenopausal cyclic estrogen-progestin therapy lowers lipoprotein[a].
    Mendoza S; Velazquez E; Osona A; Hamer T; Glueck CJ
    J Lab Clin Med; 1994 Jun; 123(6):837-41. PubMed ID: 8201261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No effect of oral hormone replacement therapy on platelet function in postmenopausal women with coronary artery disease.
    Håkan Wallén N; Li N; Eriksson-Berg M; Landgren BM; Schenck-Gustafsson K; Hjemdahl P
    Thromb Haemost; 2006 Dec; 96(6):862-3. PubMed ID: 17139389
    [No Abstract]   [Full Text] [Related]  

  • 7. PEPI in perspective. Good answers spawn pressing questions.
    Healy B
    JAMA; 1995 Jan; 273(3):240-1. PubMed ID: 7807665
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women.
    Lamon-Fava S; Posfai B; Schaefer EJ
    Am J Cardiol; 2003 Jan; 91(2):252-4. PubMed ID: 12521647
    [No Abstract]   [Full Text] [Related]  

  • 9. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
    Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
    Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxytocinergic activity is linked to lower blood pressure and vascular resistance during stress in postmenopausal women on estrogen replacement.
    Light KC; Grewen KM; Amico JA; Brownley KA; West SG; Hinderliter AL; Girdler SS
    Horm Behav; 2005 May; 47(5):540-8. PubMed ID: 15811355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin attenuates increase in C-reactive protein during estrogen replacement therapy in postmenopausal women.
    Wakatsuki A; Okatani Y; Fukaya T
    Circulation; 2002 Dec; 106(24):e198-9; author reply e198-9. PubMed ID: 12473568
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of postmenopausal hormone replacement therapy on sympathetic skin response.
    Sahiner T; Aktan E; Kaleli B; Oguzhanoglu A
    Maturitas; 1998 Sep; 30(1):85-8. PubMed ID: 9819788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulse pressure and coronary atherosclerosis progression in postmenopausal women.
    Nair GV; Waters D; Rogers W; Kowalchuk GJ; Stuckey TD; Herrington DM
    Hypertension; 2005 Jan; 45(1):53-7. PubMed ID: 15545509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal smokers show reduced hemodynamic benefit from oral hormone replacement.
    Girdler SS; Hinderliter AL; West SG; Grewen K; Steege J; Light KC
    Am J Cardiol; 2000 Sep; 86(5):590-2, A10. PubMed ID: 11009291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D; Yeşildaglar N; Erkaya S
    Gynecol Endocrinol; 2005 Apr; 20(4):209-12. PubMed ID: 16019363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term effects of hormone therapy on serum C-reactive protein levels in postmenopausal women.
    Kiran H; Kiran G
    Arch Gynecol Obstet; 2006 Apr; 274(1):9-12. PubMed ID: 16369811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS; Carlström K; Jonsson B; Jonasson AF
    Maturitas; 2006 Jan; 53(1):89-96. PubMed ID: 15964160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate.
    Odmark IS; Jonsson B; Bäckström T
    Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.